Report overview
The global Peripheral Vasodilator Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Calcium Channel Blockers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Peripheral Vasodilator Drugs include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca, Merck & Co., Inc., Sanofi, Bayer AG, Abbott Laboratories and Bristol-Myers Squibb Company, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.
This report aims to provide a comprehensive presentation of the global market for Peripheral Vasodilator Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Vasodilator Drugs. This report contains market size and forecasts of Peripheral Vasodilator Drugs in global, including the following market information:
Global Peripheral Vasodilator Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Peripheral Vasodilator Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Peripheral Vasodilator Drugs companies in 2023 (%)
We surveyed the Peripheral Vasodilator Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripheral Vasodilator Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Peripheral Vasodilator Drugs Market Segment Percentages, by Type, 2023 (%)
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others
Global Peripheral Vasodilator Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Peripheral Vasodilator Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Retail Pharmacies
Others
Global Peripheral Vasodilator Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Peripheral Vasodilator Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peripheral Vasodilator Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Peripheral Vasodilator Drugs revenues share in global market, 2023 (%)
Key companies Peripheral Vasodilator Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Peripheral Vasodilator Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peripheral Vasodilator Drugs, market overview.
Chapter 2: Global Peripheral Vasodilator Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Peripheral Vasodilator Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peripheral Vasodilator Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peripheral Vasodilator Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
